There is sparse information on patterns of opioid use among opioid-na€ ıve surgical patients. This prospective observational study investigated patterns of opioid prescribing after hospital discharge, opioid use at 1 week and 1, 3 and 6 months after discharge, and associations between opioid use, pain control and opioid-related difficulties in opioid-na€ ıve surgical patients (age ≥18 years, not prescribed opioids in the previous 12 months, expected hospital length of stay >24 h after surgery). Of 128 participants recruited, 56.3% (n = 72) were male with a median (interquartile range) age of 66 (50.7-73.0) years; 38.3% (n = 49) were discharged with an opioid prescription postoperatively. After discharge, 37.3% (n = 25/67), 12.3% (n = 8/65), 12.5% (n = 6/48) and 2.4% (n = 1/42) of participants had used an opioid within 1 week and 1, 3 and 6 months, respectively. Low levels of pain were experienced overall postoperatively. There was considerable variation in opioid-related problems and concerns over time, with the most common being the desire to cease the opioid. Follow-up response rates were low, which limits the conclusions that can be drawn from the data. However, the findings indicate that opioids are commonly prescribed at discharge to opioid-na€ ıve surgical patients, with significant decline in use over time.
INTRODUCTION
Opioids are commonly used postoperatively due to their effectiveness in managing moderate to severe pain. 1 However, current evidence suggests that patients who first start using opioids after discharge from surgery may use them chronically (>3 months postoperatively). 2 This is concerning given the harms associated with chronic opioid use, including dependence, diversion, increased hospitalisations and mortality. [3] [4] [5] To date, there is a paucity of studies investigating the patterns of opioid prescribing in the postsurgical setting, with most studies being conducted in North America. 6 A recent Australian study found that 10.5% of privately insured opioid-na€ ıve patients used opioids for more than 3 months after surgery. 6 It is critical to better characterise the use of opioids postoperatively given the potential for chronic use and associated harms seen in the broader use of opioids in non-cancer pain. Therefore, we conducted an observational study investigating the prescribing patterns of opioids after hospital discharge among Australian opioid-na€ ıve surgical patients, the patterns of opioid use 1 week and 1, 3 and 6 months after discharge, and the associations between opioid use, pain control and opioid-related difficulties.
METHODS
Participants scheduled to have any surgery undertaken at the Royal North Shore Hospital (RNSH), a tertiary hospital in Sydney (NSW, Australia), were recruited from the Pre-Admission Clinic. The recruitment period was from July to October 2016. Patients were invited to participate in the study if they were age ≥18 years and had not been prescribed any opioid analgesic in the past year. The study was approved by the Northern Sydney Local Health District Human Research Ethics Committee (LNR/16/HAWKE/207).
After consent was obtained, the pharmacy research student (LDK) undertook a structured interview with participants to gather information regarding sociodemographic characteristics and clinical history. The Brief Pain Inventory (BPI) 7 was used to capture pain severity and interference with normal functioning. Preoperative analgesic use and the nature of the patients' surgery were recorded. Following hospital discharge, all prescribed medications (including strength and dose) were recorded from the discharge summary accessed through the electronic medical record by the pharmacy research student (LDK and TYK). Opioid doses were converted to daily oral morphine equivalent (OME) dose (the maximum daily dose was used for 'when required' (PRN) opioids). 8 Participants were contacted 1 week and 1, 3 and 6 months after discharge to complete the follow-up survey. At each follow-up, participants were asked whether they had used any opioid analgesic (including over-thecounter analgesics) since the previous follow-up and to list any other analgesics they had taken that were not previously recorded. Common opioid adverse drug events (ADEs) identified using the Australian Medicines Handbook 9 were captured, and postoperative pain was measured using the BPI. 7 Participants reporting opioid use since the previous follow-up, opioid-related difficulties were assessed using the Prescribed Opioids Difficulties Scale (PODS) 10 to determine patients' difficulties in managing any opioid-related problems experienced and concerns about controlling the quantity of opioids taken (Table 1) . Descriptive statistics and frequencies were used to analyse the baseline data and patterns of opioid use. To compare data between discharge and follow-up periods, related-samples Wilcoxon signed-rank tests were used. The Mann-Whitney U-test was used to compare opioid prescribing patterns and participants' corresponding pain scores.
RESULTS
In all, 262 patients were screened for eligibility, with 125 (47.7%) patients being excluded (91 not opioid na€ ıve, 34 unwilling to participate) and 137 patients consenting to take part in the study. Of those recruited to the study, 6.6% (n = 9) did not have their operation at the RNSH leaving 128 participants remaining in the study. The median (interquartile range) age was 66.0 (50.7-73.0) years and 56.3% (n = 72) were male. In all, 33.6% of Table 1 Pain control and opioid-related difficulties at baseline and after hospital discharge One and two of 48 patients did not complete the BPI pain severity and pain interference surveys, respectively, at 3 months. One patient each (of 6) did not have a PODS problem score or a concern score at 3 months. d One patient each (of 42) did not complete the pain severity and pain interference surveys at 6 months. One of one patients did not have a PODS concern score at 6 months. The participant did not respond to one of the questions, so the PODS concern score was calculated from the other responses.
participants (n = 43) were using regular analgesics prior to their surgery, most commonly paracetamol (26.6%; n = 34). A range of surgical procedures was undertaken, with the most common being cardiothoracic (20.3%), orthopaedic (14.1%) and gynaecological (13.3%).
Of the 128 participants, 38.3% (n = 49) were discharged with an opioid, including 10.2% (n = 13) who were discharged with two opioids. Oxycodone PRN (83.7%; n = 41) was the most frequently prescribed opioid, followed by oxycodone/naloxone twice daily (34.7%; n = 17), codeine PRN (6.1%; n = 3) and tramadol PRN (2.0%; n = 1). The median (IQR) daily oral morphine equivalent dose was 45 (30) mg, ranging from 24 to 120 mg. In addition, in 85.7% of patients (n = 42), opioids were coprescribed with another non-opioid analgesic. Among patients prescribed non-opioid analgesics (62.5%; n = 80), paracetamol (98.8%; n = 79) was most commonly prescribed.
The follow-up response rate was low and some participants withdrew from the study, with 52.3% (n = 67/128) completing the 1-week follow-up, 56.5% (n = 65/115) completing the 1-month follow-up, 45.3% (n = 48/106) completing the 3-month follow-up and 42.0% (n = 42/100) completing the 6-month follow-up. Within 1 week after discharge, 37.3% (n = 25) of participants used an opioid (Figure 1 ). This was not significantly different from the proportion of patients discharged with an opioid (p = 0.453). At 1, 3 and 6 months after discharge, 12.3% (n = 8), 12.5% (n = 6) and 2.4% (n = 1) of participants used an opioid, significantly lower than the proportion of patients using an opioid at discharge (p < 0.001, p = 0.01 and p < 0.001, respectively).
The most commonly experienced problem and concern from the PODS related to sedation (65.2%, 42.9%, 40.0% and 100% at 1 week and 1, 3 and 6 months after discharge, respectively) and the desire to cease the opioid (62.5%, 75.0%, 40.0% and 100% at 1 week and 1, 3 and 6 months after discharge, respectively). The most commonly reported ADEs at 1 week and 1, 3 and 6 months after discharge were drowsiness or tiredness (88.0%, 82.5%, 50.0% and 100%, respectively), followed by nausea or vomiting (72.0%, 50.0%, 16.7% and 0%, respectively) and constipation (56.0%, 37.5%, 33.3% and 100%, respectively).
DISCUSSION
The present study is one of the first Australian studies to investigate opioid prescribing patterns following hospital discharge after a wide variety of surgeries, as well as opioid-related harms experienced by opioid-na€ ıve patients after surgery. The main findings of the study were that opioids are commonly prescribed at discharge after surgery (38.3%) among opioid-na€ ıve patients. There is a significant decline in the number of opioid users after discharge with a small but clinically important group using opioids long term.
Previous studies assessing patterns of opioid use after surgery among opioid-na€ ıve patients report varying proportions of patients using opioids during the postoperative period. At 90 days after surgery, across a number of studies, the proportion of opioid users varied between 3.1% and 13.5%, 2,6,11-13 with significant variation by procedure. 6,13 After 12 months, Alam et al. 14 found that 10.3% of patients had used opioids continually since their operation. Evidently, there will be a relatively small proportion of patients who persistently use opioids for a long time after surgery, and the results of the present study reflect this in our Australian population. However, despite the small part of the total surgical population represented, it is these patients who are at greatest risk of opioid-related harm. In order to address this issue, early identification and interventions for these patients must be developed. The highest proportion of opioid users, as well as the highest pain scores, were observed during the first postoperative week, with a decline in both at each subsequent follow-up. This reflects the natural progression after surgery, where it should be expected that although patients are well enough to be discharged, it will still take time for them to fully recover. Multimodal analgesia was commonly prescribed (see Figure 1) , and many patients were managed well without opioids, in line with recent guidelines, 15 which may have contributed to low rates of long-term opioid use. It is difficult to balance managing pain while preventing opioid harms. PODS scores varied between each follow-up, with the small number of users and incomplete responses limiting the conclusions able to be drawn from the data. However, the most commonly experienced concern related to the desire to reduce or cease opioids. In the Royal Australasian College of Physicians (RACP) EVOLVE guidelines, the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT) recommends to 'Stop medicines when no further benefit will be achieved or the potential harms outweigh the potential benefits'. 16 All health professionals play a role in partnering with patients to achieve satisfactory pain relief without introducing unacceptable harms. In particular, education, advice to doctors on appropriate dose and quantity to prescribe, and regular contact with patients allows pharmacists to monitor for opioid-related problems.
The present study provides critical data to inform the judicious prescribing of opioids in this postoperative setting. In particular, the follow-up intervals chosen enabled temporal data to be collected and trends demonstrated. However, the present study has important limitations that should be considered. The number of patients responding to the follow-up survey was low and there were participants who did not provide complete followup data. To overcome significant loss to follow-up, future studies could obtain consent from participants to be followed-up using more than one method if necessary (e.g. telephone and e-mail) or to use administrative health databases to access outcome data.
The present study was conducted in one teaching hospital in Sydney, Australia, so may not be generalisable to other settings or other countries. The results of the present study need to be confirmed in other settings.
Overall, the results of the present study indicate that opioids are commonly prescribed at discharge to opioidna€ ıve surgical patients, with significant decline in usage over time. There was a small but clinically important group who used opioids long term. Future research is needed to confirm these findings, as well to develop strategies limiting the chronic use of opioids postoperatively.
